JPJelica Predojevic-Samardzic

Jelica Predojevic-Samardzic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jelica Predojevic-Samardzic has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in children with ventricular septal defect

    by Nina Maric, Ines Mrakovcic Sutic, Jelica Predojevic Samardzic, Dario Djukic, Aleksandar Bulog, Ivana Sutic

    Ventricular septal defect (VSD) is the second most common congenital heart anomaly. In most cases, it closes spontaneously in the first year of life, but it sometimes requires surgical closure due to the risk of serious complications. This is why it is important to identify markers that could help predict its course. Findings that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play an important role in the cleavage of the extracellular matrix were the reasons to investigate their role in cardiogenesis. In prior studies on this topic, their concentrations were studied in the blood. The aim of this prospective study was to investigate the role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the etiology and pathophysiology of VSD using urine samples, as an innovative non-invasive approach, and the enzyme-linked immunosorbent assay (ELISA) method. It involved 52 children with isolated VSD and 20 healthy children up to one year of age. We found that these MMPs and TIMPs are significantly (P = 0.000) higher in children with VSD, and the correlations between their concentrations and the size of the defect are positive, especially for MMP-9 and TIMP-1. MMP-9 was significantly (P = 0.044) higher in cases in which VSD did not close in the first year of life compared to cases in which it closed. Our results suggest the role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the aetiopathogenesis of VSD and that their urinary concentrations, especially of MMP-9, in combination with echocardiographic and clinical monitoring, could be useful in predicting its natural course.

  • Open Access

    Intolerance of gluten-containing cereals

    by Zoran Lekovic, Vladimir Radlovic, Marija Mladenovic, Sinisa Ducic, Petar Rosic, Goran Djuricic, Jelica Predojevic-Samardzic, Nedeljko Radlovic

    Intolerance of gluten containing cereals (wheat, rye, and barley) is an etiopathogenetically heterogeneous and relatively common problem of modern man. It occurs as an adverse immune-mediated condition in genetically predisposed individuals. According to the pathogenetic mechanism of intolerance to the components of these cereals, it is classified into celiac disease as an autoimmune disease, wheat allergy as an allergic disease, and non-celiac gluten sensitivity as a non-autoimmune and non-allergic disease. Each of these disorders is characterized by specific intestinal and/or extraintestinal manifestations, which resolve on a gluten-free diet. This review article presents the basic characteristics of these disorders in accordance with modern knowledge.


  • Open Access

    Hepcidin as a biomarker of neonatal infections

    by Jelica Predojevic-Samardzic, Dragana Malcic-Zanic, Zelimir Eric, Gordana Guzijan, Sergej Samardzic

    Introduction/Objective. Nonspecific clinical signs of neonatal infection dictate routinely determination of C-reactive protein (CRP) and procalcitonin levels in order to confirm the diagnosis. As hepcidin is an acute phase reactant, the aim of our study was to analyze its significance in diagnosis of neonatal infections. Methods. The prospective study included 71 term neonates, 37 with signs of infection in the absence of other pathological conditions and 34 healthy neonates. After standard bacteriological examination, at the time of diagnosis and after six days of antibiotic therapy, complete blood count, serum CRP, procalcitonin, and hepcidin were determined. Results. There was no difference in serum hepcidin levels between the control (55.17 ? 21.22 ng/ml) and the infection group (59.72 ? 59.7 ng/ml) on the first day. Hepcidin values in neonates with infection up to 72 hours were significantly lower (30.2 ng/ml, IQ: 25.9?39.9 ng/ml) than in older neonates (82.2 ng/ml, IQ: 39.7?128.1 ng/ml). In neonates up to 72 hours, after six days of antibiotics, the hepcidin values show a significant increase (36.68 ng/ml, IQ; 31.23?50.3 ng/ml). High hepcidin values (128.05 ng/ml, IQ: 60.95?201 ng/ml) were recorded in neonates with CRP over 100 mg/l. Conclusion. Our results shows that the determination of serum hepcidin as a marker of neonatal infection is not relevant in neonates up to 72 hours of life. After six days of antibiotic therapy, the neonates of this group reacted with an increase in hepcidin, while the parallel determined values of CRP and procalcitonin showed a significant decrease.